输血相容性检测试验室内质控品的制备与可行性分析

来源 :临床血液学杂志(输血与检验) | 被引量 : 0次 | 上传用户:xtopg
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨利用基层输血科现有资源配制输血相容性检测试验室内质控品,建立符合本实验室的质控方法。方法:回顾性分析2015-06-2016-06配制的输血相容性检测室内质控品(ABO血型鉴定、RhD血型鉴定、不规则抗体筛查、交叉配血)的稳定性和均一性,并与商品化室内质控品结果比较,评价自制室内质控品的临床可行性。结果:自制输血相容性检测室内质控品与商品化质控品在批内稳定性及重复性检测、批间检测差异均无统计学意义(P>0.05)。结论:自制输血相容性检测室内质控品批间差小,抗原抗体反应稳定性好,可以满足输血相容性检测室内质量控制的基本要求。 Objective: To explore the use of the existing resources of primary blood transfusion department to prepare blood transfusion compatibility testing laboratory quality control products, and to establish a quality control method that accords with our laboratory. Methods: The stability and homogeneity of blood transfusion compatibility test (ABO blood group identification, RhD blood group identification, irregular antibody screening, cross-matching blood) prepared during 2015-06-2016-06 were retrospectively analyzed. Compared with the results of commercial indoor control products, evaluate the clinical feasibility of homemade indoor control products. Results: There was no significant difference in the stability and repeatability of intra-assay and inter-assay between self-made blood transfusion compatibility test control and commercial quality control test (P> 0.05). Conclusion: The self-made blood transfusion compatibility test difference between indoor control products is small, good antigen-antibody reaction stability, can meet the basic requirements of blood compatibility testing of indoor quality control.
其他文献
造血干细胞移植是多种血液系统疾病治疗的有效手段,血小板减少是造血干细胞移植后常见并发症,国内外报道发生率为5%~37%[1].其病因复杂,治疗难度大,是移植的主要不良预后因素之
天下佳作汇河南,浓浓书香飘中原,4月26日,第十八届全国图书交易博览会在河南郑州开幕,开封、洛阳、安阳几个分会场也相继闪亮开幕。上午10点40分,第十届全国人大常委会副委
鸡西矿业集团公司张辰煤矿西三采区3
期刊
多发性骨髓瘤(multiple myeloma,MM)是B淋巴细胞来源的血液系统恶性增殖性疾病,以骨髓中单克隆浆细胞异常增殖为特征,临床上主要表现为贫血、高钙血症、肾功能不全、骨破坏等
目的:观察阻断肾素-血管紧张素-醛固酮系统不同部位对高血压左室肥厚(LVH)及心肌纤维化的逆转作用.方法:对26周龄自发性高血压大鼠(SHR)分别采用血管紧张素转换酶抑制剂(ACEI